Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
Early results indicate the process could reduce sample preparation time by approximately 40% to 50%, while improving consistency by removing variability linked to staining conditions.
The company’s product, Slideflow Pro, is a scalable and modular platform designed to analyze digitized pathology slides and support the development of AI-based biomarkers that can help answer clinically important questions in cancer care.
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.
Elevated donor-derived cell-free DNA levels are linked to higher kidney transplant failure risk, suggesting earlier detection of allograft injury before loss of kidney function.
The assay is CE marked under the European Union In Vitro Diagnostic Regulation and identifies resistance genes to help prevent hospital-acquired infections.
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.
A study reports that long-read genome sequencing can replace up to 15 separate tests and improve diagnostic yield for rare genetic disorders, according to researchers in the Netherlands.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.